Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Mar 30, 2011


PrognosDx Health announced that A. Franklin Rice has joined its board of directors. Rice is a member of BayBio Northern California's Life Science Association and "brings a wealth of experience in finance and administration to PrognosDx's board of directors," the company said in a statement.

Rice is currently the chief financial officer of the stem cell-based drug company VistaGen Therapeutics. He has held various positions in the biotech industry for 20 years.

According to documents filed with the US Securities and Exchange Commission, Genomic Health announced that Brook Byers will retire from its board of directors as of June 9. Byers has been a member of Genomic Health's board since 2001.

Byers is a senior partner at Kleiner Perkins Caufield & Byers. Since becoming a venture capital investor in 1972, he as been intimately involved with launching more than fifty technology companies.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.